Original Research
Published on 22 Jan 2019
Liver-Targeted Combination Therapy Basing on Glycyrrhizic Acid-Modified DSPE-PEG-PEI Nanoparticles for Co-delivery of Doxorubicin and Bcl-2 siRNA
in Cancer Molecular Targets and Therapeutics
Frontiers in Pharmacology
doi 10.3389/fphar.2019.00004
- 10,379 views
- 44 citations


